Genome sequencing can identify hidden cancer
New York, Dec 24: Researchers have found that whole-genome sequencing can be used to identify patients' risk for hereditary cancer, which can potentially lead to improvements in cancer prevention, diagnosis and care. The team from University of Texas' Southwestern Medical Centre used whole-genome sequencing to evaluate a series of 258 cancer patients' genomes to improve the ability to diagnose cancer-predisposing mutations. Whole-genome sequencing is a new genetic tool that can determine more of a person's DNA sequence than ever before. The study was published online in the journal EBioMedicine.